METHOD OF TREATING PATIENTS WITH LOCALISED SCLERODERMA Russian patent published in 2015 - IPC A61K9/08 A61K31/711 A61P17/02 A61P37/02 A61K35/60 

FIELD: medicine.

SUBSTANCE: as a novel method of increasing the efficiency of treating localised scleroderma claimed is a method of treatment with deoxynate, which is characterised by high efficiency with the shorter treatment course duration in comparison with other therapeutic methods. The method of treating localised scleroderma consists in the additional application of deoxynate at the background of standard therapy in the form of a 0.5% injection solution with an active component of sodium deoxyribonucleate - sodium salt of partly depolymerised deoxyribonucleic acid, isolated from milts of the sturgeon, 0.005 g in a dose of 5 ml intramuscularly every second day with the course up to 10 days.

EFFECT: method of treating patients with localised scleroderma makes it possible to obtain noticeable immunomodulating and therapeutic effect, favourable impact on the disease course, prolongation of remission, does not cause side effects and allergic reactions, results in the normalisation of the clinical pattern of the disease.

3 ex